| 摘要 |
The present invention relates to a method for diagnosis of acute myeloid leukemia, and more particularly to a method of using CFH (complement factor H) or ApoH (apolipoprotein H) present in the serum of a patient as a biochemical marker for diagnosis of acute myeloid leukemia. According to the method of the present invention, a new biochemical marker is provided for identifying a biological mechanism of human body responses for the treatment of acute myeloid leukemia and the invention is able to diagnose exactly whether the prognosis of the disease is positive or not by the concentration of the biochemical marker. |
